Bulletin of Experimental Biology and Medicine

, Volume 84, Issue 3, pp 1268–1270 | Cite as

Phospholipids and cholesterol of the brain and spinal cord of guinea pigs poisoned with tricresyl phosphate

  • N. P. Taranova
  • É. Illiger
Biochemistry and Biophysics


The content of phospholipids and of total, free, and esterified cholesterol in the brain and spinal cord of guinea pigs with severe neuroparalytic signs of poisoning caused by intradermal injection of tricresyl phosphate (TCP) was investigated. No change was found in the content of phospholipids and total cholesterol in either the brain or the spinal cord, but accumulation of cholesterol esters—the characteristic degradation products of myelin sheaths-was observed.

Key Words

tricresyl phosphate phospholipids cholesterol demyelination spinal cord 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literature Cited

  1. 1.
    V. S. Aizenshtadt, Gig. Truda, No. 3, 23 (1975).Google Scholar
  2. 2.
    A. S. Belokhvostov, I. P. Katsnel'son, and N. P. Taranova, Vopr. Med. Khim., No. 2, 115 (1974).Google Scholar
  3. 3.
    É. A. Dvorkin, in: All-Union Scientific Conference of Junior Scientific Workers on Work Hygiene and Occupational Pathology [in Russian], Moscow (1971), p. 35.Google Scholar
  4. 4.
    Yu. D. Zil'ber, “Effect of tricresyl phosphate on myelin sheaths and its membranotoxic action,” Author's Abstract of Doctoral Dissertation, Moscow (1971).Google Scholar
  5. 5.
    J. M. Barnes, in: The Scientific Bases of Medicine. Annual Reviews, London (1960), p. 183.Google Scholar
  6. 6.
    G. K. Bartlett, J. Biol. Chem.,234, 466 (1959).Google Scholar
  7. 7.
    J. F. Berry and W. H. Cevallos, J. Neurochem.,13, 117 (1966).Google Scholar
  8. 8.
    A. Bischoff, in: Proceedings of the 7th International Congress of Neuropathology, Vol. 2, Budapest (1975), p. 373.Google Scholar
  9. 9.
    A. N. Davison, J. Dobbing, R. S. Morgan, et al., J. Neurochem.,3, 89 (1958).Google Scholar
  10. 10.
    J. N. Cummings, Neuropatol. Pol.,7, 255 (1969).Google Scholar
  11. 11.
    B. Maggio, F. A. Cumar, and H. J. Maccioni,J. Neurochem.,19, 1031 (1972).Google Scholar
  12. 12.
    R. Morazain and P. Rosenberg, Toxicol. Appl. Pharmacol.,16, 461 (1970).Google Scholar
  13. 13.
    G. Porcellati and M. A. Mastrantonio, Ital. J. Biochem.,13, 332 (1964).Google Scholar
  14. 14.
    J. D. Taylor, Canad. J. Physiol. Pharmacol.,43, 715 (1965).Google Scholar
  15. 15.
    C. H. Williams, H. J. Johnson, and J. L. Casterline, J. Neurochem.,13, 471 (1966).Google Scholar

Copyright information

© Plenum Publishing Corporation 1978

Authors and Affiliations

  • N. P. Taranova
  • É. Illiger

There are no affiliations available

Personalised recommendations